UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives

Gastroenterology research and practice, 2018-01, Vol.2018 (2018), p.1-21

2018

Volltextzugriff (PDF)

Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial

Annals of oncology, 2015-06, Vol.26 (6), p.1201-1207

2015

Volltextzugriff (PDF)

Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis

Gastroenterology research and practice, 2018-01, Vol.2018 (2018), p.1-7

2018

Volltextzugriff (PDF)

Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio

Gastroenterology research and practice, 2018-01, Vol.2018 (2018), p.1-9

2018

Volltextzugriff (PDF)

Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies

Annals of oncology, 2019-12, Vol.30 (12), p.1969-1977

2019

Volltextzugriff (PDF)

Surgical Management of Gastric Gastrointestinal Stromal Tumours: Comparison of Outcomes for Local and Radical Resection

Gastroenterology research and practice, 2018-01, Vol.2018 (2018), p.1-7

2018

Volltextzugriff (PDF)

Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways

Gastroenterology research and practice, 2015-01, Vol.2015 (2015), p.1-10

2015

Volltextzugriff (PDF)

Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases

Gastroenterology research and practice, 2018-01, Vol.2018 (2018), p.1-4

2018

Volltextzugriff (PDF)

Treatment of squamous cell carcinoma of the anal canal (SCCA): a new era?

Annals of oncology, 2017-10, Vol.28 (10), p.2620-2620

2017

Volltextzugriff (PDF)

Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials

Gastroenterology research and practice, 2016-01, Vol.2016 (2016), p.1-9

2016

Volltextzugriff (PDF)

Association of eNOS Gene Polymorphisms G894T and T-786C with Risk of Hepatorenal Syndrome

Gastroenterology research and practice, 2016-01, Vol.2016 (2016), p.1-7

2016

Volltextzugriff (PDF)

Treatment of squamous cell carcinoma of the anal canal: A new strategies with anti-EGFR therapy and immunotherapy

Critical reviews in oncology/hematology, 2018-03, Vol.123, p.52-56

2018

Volltextzugriff (PDF)

Prognostic role of aspartate aminotransferase-lymphocyte ratio index (ALRI) in patients with metastatic colorectal cancer: results from the ITACa trial

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi13

2017

Volltextzugriff (PDF)

Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?

Gastroenterology research and practice, 2016-01, Vol.2016 (2016), p.1-5

2016

Volltextzugriff (PDF)

Adjuvant Second-Dose Chemotherapy before Surgery for Patients with Locally Advanced Rectal Malignancy Is Not Beneficial: A Systematic Review and Meta-Analysis

Gastroenterology research and practice, 2017-01, Vol.2017 (2017), p.1-8

2017

Volltextzugriff (PDF)

Serum angiogenesis associated proteins and clinical outcome in metastatic colorectal cancer patients receiving bevacizumab

Annals of oncology, 2018-06, Vol.29, p.v59-v59

2018

Volltextzugriff (PDF)

TRIBE2: A phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts)

Annals of oncology, 2018-10, Vol.29, p.viii715-viii715

2018

Volltextzugriff (PDF)

Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC

Annals of oncology, 2019-07, Vol.30, p.iv154-iv154

2019

Volltextzugriff (PDF)

GEMOX plus hypofractionated radiotherapy for unresectable locally advanced pancreatic cancer: Results from a phase II study

Annals of oncology, 2018-10, Vol.29, p.viii249-viii249

2018

Volltextzugriff (PDF)

The role of adjuvant therapy in resectable SBA: A different clinicians attitude with a relevant impact on outcome

Annals of oncology, 2018-10, Vol.29, p.viii264-viii264

2018

Volltextzugriff (PDF)

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial

ESMO open, 2023-10, Vol.8 (5), p.101824-101824, Article 101824

2023

Volltextzugriff (PDF)

Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction

Gastroenterology research and practice, 2015-01, Vol.2015 (2015), p.1-9

2015

Volltextzugriff (PDF)

Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset

ESMO open, 2024-04, Vol.9 (4), p.102996, Article 102996

2024

Volltextzugriff (PDF)

Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A “real life” study

European journal of cancer (1990), 2017-02, Vol.72, p.S87-S87

2017

Volltextzugriff (PDF)

Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience

ESMO open, 2022-06, Vol.7 (3), p.100506, Article 100506

2022

Volltextzugriff (PDF)

1 – 25 von 317

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(280)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives

Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial

Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis

Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio

Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies

Surgical Management of Gastric Gastrointestinal Stromal Tumours: Comparison of Outcomes for Local and Radical Resection

Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways

Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases

Treatment of squamous cell carcinoma of the anal canal (SCCA): a new era?

Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials

Association of eNOS Gene Polymorphisms G894T and T-786C with Risk of Hepatorenal Syndrome

Treatment of squamous cell carcinoma of the anal canal: A new strategies with anti-EGFR therapy and immunotherapy

Prognostic role of aspartate aminotransferase-lymphocyte ratio index (ALRI) in patients with metastatic colorectal cancer: results from the ITACa trial

Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?

Adjuvant Second-Dose Chemotherapy before Surgery for Patients with Locally Advanced Rectal Malignancy Is Not Beneficial: A Systematic Review and Meta-Analysis

Serum angiogenesis associated proteins and clinical outcome in metastatic colorectal cancer patients receiving bevacizumab

TRIBE2: A phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts)

Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC

GEMOX plus hypofractionated radiotherapy for unresectable locally advanced pancreatic cancer: Results from a phase II study

The role of adjuvant therapy in resectable SBA: A different clinicians attitude with a relevant impact on outcome

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial

Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction

Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset

Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A “real life” study

Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience

Suchergebnisse filtern